Showing 850 – 860 of 1159 results
-
Reshoring AI and the New Infrastructure Boom
William Blair energy and environmental services analyst Tim Mulrooney and macro analyst Richard de Chazal explore how reshoring, AI infrastructure, and labor and energy challenges are driving transformation across the U.S. economy.
-
How a Cancer Diagnosis Changed a Family Foundation’s Giving
Learn how William Blair clients are engaging in multigenerational philanthropic giving to invest in research, advocacy, and patient education.
-
Generational Healthcare and Wealth Preservation Tips
With the rising costs of today’s healthcare needs and the challenges that social programs such as Medicare may face in coming decades, we provide an array of tips and tactics to help clients of all ages better plan for, and protect, their wealth and well-being.
-
Monthly Macro with Richard de Chazal 2024 Outlook
Macro analyst Richard de Chazal reflects on the resilient year and expands on his 2024 Outlook’s key themes, including the sticky pockets of inflation, the 3 keys the Fed needs to achieve success next year, Treasury Secretary Yellen’s “Operation Twist” reboot, and more.
-
Furniture and Home Renovations Post Pandemic Normalization and the Next Era of Growth
William Blair consumer analyst Phillip Blee joins William Blair Thinking Presents to explore the volatile demand for furniture and home improvement projects over the past four years and provide insights into the industry’s 2024 outlook, including key themes such as the housing market, deflation, rising ocean freight costs, and long-term growth potential.
-
Erik Birkerts, CEO of Clean Energy Trust, Helps Climate Innovators Bring Ideas to Market
Working on solutions to fight climate change, creating a zero-carbon future.
-
How Ukraine Changed Our Outlook
William Blair’s Olga Bitel shares insights on how the Russia-Ukraine crisis is impacting markets and outlooks.
-
Century Therapeutics Inc Initiation
William Blair initiated research coverage of Century Therapeutics, Inc. (IPSC $9.04), a biotechnology company focused on developing allogeneic iPSC-derived cellular immunotherapies, including CAR-NK and CAR-T cell therapies, for the treatment of cancer.
-
Lantheus Holdings Inc Initiation
William Blair initiated research coverage of Lantheus Holdings, Inc. (LNTH $65.90), a commercial-stage radiopharmaceuticals biotechnology company that markets Pylarify for imaging prostate cancer.
-
SharkNinja Inc Initiation
William Blair initiated research coverage of SharkNinja, Inc. (SN $42.45), a dual-brand portfolio specializing in the design and innovation of household products and small appliances sold globally.